Similar Articles
1511 Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib
1512 Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma
1513 Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: A meta-analysis
1514 Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma
1515 DEC1 nuclear expression: A marker of differentiation grade in hepatocellular carcinoma
1516 Acoustic radiation force impulse elastography for hepatocellular carcinoma-associated radiofrequency ablation
1517 Risk factors for residual tumor after resection of hepatocellular carcinoma
1518 Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma
1519 Therapeutic options for intermediate-advanced hepatocellular carcinoma
1520 β-catenin accumulation in nuclei of hepatocellular carcinoma cells up-regulates glutathione-s-transferase M3 mRNA
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA